Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Mayo Clinic Cancer Center finds better predictors for outcomes after radical prostatectomy

14.11.2005


Speed of PSA increase matters more than PSA level



In the largest study of its kind to date, Mayo Clinic researchers report that prostate specific antigen (PSA) kinetics, both velocity and doubling time, can be used to predict disease progression and likelihood of death after radical prostatectomy surgery, suggesting that this could be used to guide treatment decisions. Study results are published in the December issue of The Journal of Urology.

"The level of PSA in the blood has less prognostic value than we previously thought, and we don’t have another serum marker to help us," says Michael Blute, M.D., Mayo Clinic urologist and lead investigator of the study. "It was important for us to find other ways to look at PSA data and translate that into information that will save lives, and I believe we have done that."


Prostate cancer is the second most common cancer in men (skin cancer is first) and the second leading cause of cancer death in American men, exceeded only by lung cancer. This year, the American Cancer Society estimates 232,000 new cases of prostate cancer will be diagnosed. While one in six men will be diagnosed with prostate cancer in his lifetime, only one in 33 will die of it. However, because it causes disability and death, finding new strategies to better target treatments is an important public health goal.

Dr. Blute and his fellow researchers reviewed the records of 2,290 patients with multiple preoperative PSA measurements, as well as 5,176 patients with only one preoperative measurement, looking at the rate at which PSA increased in the body -- thought to indicate cancer growth. This was measured as both the PSA velocity (PSAV), the rate of increase in PSA levels over time, and the PSA doubling time (PSADT), a measure of how quickly PSA levels double. The researchers found that while PSAV is simpler to calculate, PSADT may be a better indicator of untreated prostate cancer.

Over an average follow-up period of about seven years, cancer spread or recurrence, and deaths from cancer were recorded. Biochemical progression was noted in 25.5 percent of the patients, clinical progression in 6.8 percent and cancer death in 1.8 percent. PSAV and PSADT both predicted progression and death. PSAV greater than 3.4 ng/ml yearly correlated to men being 6.54 times more likely to die than those with lower PSAV. PSADT quicker than 18 months correlated to the risk of death being 6.22 times higher than for those with longer PSADT.

"This provides valuable pretreatment prognostic factors for prostate cancer," says primary author Shomik Sengupta, M.D. "We hope that our work will help in the doctor-patient discussion and result in more informed decisions relating to observation, intervention and adjuvant treatment."

The study group consisted of patients who had undergone radical prostatectomy for prostate cancer between 1990 and 1999 at Mayo Clinic. Preoperative and postoperative PSA measurements were obtained from referring physicians and/or Mayo laboratory testing.

Other Mayo Clinic researchers who contributed to this study include Robert Myers, M.D.; Jeffrey Slezak; Eric Bergstralh; and Horst Zincke, M.D., Ph.D.

Elizabeth Zimmermann | EurekAlert!
Further information:
http://www.mayo.edu
http://mayoresearch.mayo.edu/mayo/research/prostate_program
http://www.mayoclinic.org/prostate-cancer

More articles from Studies and Analyses:

nachricht Europe’s Demographic Future. Where the Regions Are Heading after a Decade of Crises
10.08.2017 | Berlin-Institut für Bevölkerung und Entwicklung

nachricht Scientists reveal source of human heartbeat in 3-D
07.08.2017 | University of Manchester

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

What the world's tiniest 'monster truck' reveals

23.08.2017 | Life Sciences

Treating arthritis with algae

23.08.2017 | Life Sciences

Witnessing turbulent motion in the atmosphere of a distant star

23.08.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>